PAMELA HITT: Open Payments
NPI 1003336488 · CLEMSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 37 payments from 11 companies in 2025. Trend: 2023 $562 · 2024 $937 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 4 | $201 |
| Otsuka America Pharmaceutical, Inc. | 16 | $142 |
| Novo Nordisk Inc | 1 | $123 |
| Travere Therapeutics, Inc. | 4 | $84 |
| Amgen Inc. | 3 | $73 |
| KYOWA KIRIN, INC. | 2 | $54 |
| Calliditas Therapeutics US Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $17 |
Products named: Vafseo, Ozempic, JYNARQUE, CRYSVITA, KRYSTEXXA, TARPEYO, FARXIGA, Auryxia.
Industry payments across SC — which companies pay providers there.
